Featured Post

Latest Gold News

Economic power could shift further East with Hong Kong gold exchange Russian investment bank sees $1,400 gold by end of 2017 Weak CPI...

Monday, November 21, 2011

AtriCure (ATRC) (AVII) (BBY) (BCSI) (BEN) (BRCM) Ratings, Price Targets

AtriCure (ATRC), AVI BioPharma (AVII), Best Buy Co., Inc. (BBY), Blue Coat (BCSI), Franklin Resources, Inc. (BEN) and Broadcom Corp. (BRCM) ratings and price targets.

Canaccord Genuity reiterated its “Positive” rating on AtriCure (ATRC). They have a price target of $15.50 on the company.

Wedbush lowered its price target on AVI BioPharma (AVII) to $2.50.

TheStreet upgraded Best Buy Co., Inc. (BBY) to a “Buy” rating.

Needham & Company reiterated its “Hold” rating on Blue Coat (BCSI).

JPMorgan Chase & Co. (NYSE:JPM) reiterated its “Underweight” rating on Franklin Resources, Inc. (BEN). They have a price target of $111.00 on the company.

Goldman Sachs (NYSE:GS) reiterated its “Buy” on Broadcom Corp. (BRCM). They have a price target of $41.00 on the company.

No comments: